Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?

Author:

Berzenji Lawek12,Wen Wen12,Verleden Stijn12,Claes Erik2ORCID,Yogeswaran Suresh Krishan12,Lauwers Patrick12,Van Schil Paul12ORCID,Hendriks Jeroen M. H.123ORCID

Affiliation:

1. Department of Thoracic and Vascular Surgery, University of Antwerp, 2610 Wilrijk, Belgium

2. Antwerp Surgical Training, Anatomy and Research Centre (ASTARC), Laboratory of Thoracic and Vascular Surgery, 2650 Edegem, Belgium

3. Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium

Abstract

In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference96 articles.

1. What is the role of surgery in stage III NSCLC in the era of Immunotherapy?;Addeo;Hematol. Med. Oncol.,2018

2. Neoadjuvant and adjuvant immunotherapy: Opening new horizons for patients with early-stage non-small cell lung cancer;Bai;Front. Oncol.,2020

3. Surgery after induction chemo or immunotherapy for locally advanced NSCLC;Lococo;Curr. Chall. Thorac. Surg.,2020

4. Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer;Qiu;Exp. Hematol. Oncol.,2019

5. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3